iSOFT Expands in Russia after Agreement with ML Park

iSOFTiSOFT Deutschland has strengthened its position in Russia's healthcare market after a partnership agreement with ML Park of Moscow to distribute and support iSOFT's laboratory information systems (LIS). The market in Russia offers huge potential and is set to grow at unprecedented rates. The Russian market for medical technology is worth US$2 billion a year and is growing by about 15 per cent per annum. The 'National Health Programme', which was initiated by president Putin (until 2010) provides US$1.7 billion to build 15 specialised health centres.

iSOFT has already installed its LabCentre laboratory system at KDL Test, a private laboratory chain with laboratories in Moscow, Omsk, Perm and Krasnodar. ML Park and KDL Test are sister companies and both are subsidiaries of ML Group.

iSOFT Deutschland, part of the IBA Health Group – the world's fourth largest healthcare IT provider – will focus on providing modern laboratory software solutions in Russia. Peter Herrmann, Managing Director, iSOFT Deutschland, said: "Through our partnership with ML Park we can support our Russian laboratory customers locally and develop systems to meet local needs. An early presence in this booming healthcare market is absolutely necessary. For us, this will be the basis for more efficient market cultivation and a fast and wide market penetration with our solutions.

ML Park's knowledge of laboratory systems and the private LIS market in Russia will be invaluable in establishing a support organisation in Russia."

Core elements of the agreement are the distribution, implementation and support of the leading iSOFT laboratory solution, LabCentre. iSOFT is the market leader in laboratory information systems with more than 270 installations in Germany, Switzerland, Austria, Russia and Malaysia. LabCentre is a full-graphic integrated system, covering clinical laboratory, blood donation and microbiology.

Related news articles:

About iSOFT
Following a merger completed on Tuesday 30 October, iSOFT is now part of the IBA Health Group. For further information, please visit http://www.ibahealth.com.

iSOFT products are used by more than 8,000 organisations in 27 countries for managing patient information and driving improvements in healthcare services. For further information, please visit http://www.isoftplc.com.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...